688076 ST諾泰生物
按盤價 
27.560 +0.080 (+0.291%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.078 | 11.784 | 16.756 | 8.045 | 6.976 |
| 總資產報酬率 ROA (%) | 3.115 | 5.627 | 9.381 | 5.396 | 5.563 |
| 投入資產回報率 ROIC (%) | 3.492 | 6.282 | 10.307 | 5.911 | 6.031 | 邊際利潤分析 |
| 銷售毛利率 (%) | 59.496 | 62.644 | 67.685 | 60.970 | 57.573 |
| 營業利潤率 (%) | 25.786 | 21.033 | 27.586 | 18.351 | 18.978 |
| 息稅前利潤/營業總收入 (%) | 25.506 | 21.531 | 28.123 | 17.872 | 18.693 |
| 淨利潤/營業總收入 (%) | 18.396 | 16.749 | 24.607 | 16.008 | 18.687 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 148.800 | 128.491 | 112.187 | 119.143 | 84.864 |
| 價值變動淨收益/利潤總額(%) | 3.326 | 0.976 | -0.393 | 1.826 | 14.765 |
| 營業外收支淨額/利潤總額(%) | -23.007 | -13.356 | -2.215 | -9.553 | -1.389 | 償債能力分析 |
| 流動比率 (X) | 1.137 | 1.161 | 1.144 | 1.536 | 1.909 |
| 速動比率 (X) | 0.728 | 0.764 | 0.811 | 1.148 | 1.322 |
| 資產負債率 (%) | 56.116 | 55.466 | 47.214 | 38.324 | 23.931 |
| 帶息債務/全部投入資本 (%) | 45.229 | 45.780 | 38.085 | 29.955 | 15.346 |
| 股東權益/帶息債務 (%) | 107.715 | 109.180 | 151.307 | 223.701 | 538.466 |
| 股東權益/負債合計 (%) | 77.927 | 79.858 | 110.885 | 159.534 | 315.406 |
| 利息保障倍數 (X) | 5.614 | 7.235 | 24.778 | 15.938 | -744.597 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 88.169 | 95.649 | 91.715 | 94.334 | 99.796 |
| 存貨周轉天數 (天) | 351.736 | 358.030 | 329.524 | 312.642 | 374.107 |
| 備註： | 即時報價更新時間為 27/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
